Efficacy of Bidens pilosa Extract against Herpes Simplex Virus Infection In Vitro and In Vivo

Abstract EN

The development of strains of herpes simplex virus (HSV) resistant to drugs has been reported among the immunocompromised patients.

Thus, there is a need to develop new therapeutic agents for HSV infections.

We evaluated the anti-HSV activity of Bidens pilosa (B.

pilosa), a tropical weed, in tissue culture cells and a mouse model.

B.

pilosa extract showed potent virucidal activity.

It inhibited plaque formation and suppressed virus yield in Vero and RAW 264.7 cells infected with HSV-1 and HSV-2.

Both the binding of virus to host cells and penetration of virus into cells were also blocked by B.

pilosa.

Furthermore, B.

pilosa was effective against thymidine kinase-deficient and phosphonoacetate-resistant HSV-1 strains.

B.

pilosa treatment increased the survival rate of HSV-infected mice and limited the development of skin lesions.

Our results indicate that B.

pilosa has anti-HSV activity and is thus a potentially useful medical plant for treatment of HSV infection.